The number of electronic health record systems joining with CancerLinQ to facilitate information sharing continues to grow. CancerLinQ LLC, a wholly owned nonprofit subsidiary of the American Society of Clinical Oncology, announced Varian’s ARIA Oncology Information System is the next Electronic Health Record System to be certified by CancerLinQ after meeting criteria for interoperability and data standardization. This collaboration aims to dismantle barriers to information sharing and streamline access to CancerLinQ for oncology practices using Varian ARIA OIS.
ARIA is a comprehensive electronic medical record and image management system that aggregates patient data into an organized, oncology-specific medical chart with functional components for managing clinical, administrative and financial operations for medical, radiation and surgical oncology.
The ARIA system is designed to provide a seamless flow of information for managing the patient’s entire journey—from diagnosis through follow-up.
CancerLinQ is a health information technology platform working to improve the quality of cancer care for patients by aggregating and analyzing real-world cancer data. The CancerLinQ Certified EHR program recognizes systems that meet specific requirements for interoperability and cancer data standardization.
To become a CancerLinQ Certified EHR and maintain this status, an EHR system must do the following, in addition to fulfilling other requirements:
Support the creation and maintenance of health records including, but not limited to, individually identifiable oncology and/or hematology patient information;
Maintain a leading industry standard for the recording of precise, structured, and standardized clinical data;
Meet certain federal standards for EHR technology, interoperability, privacy, and safety;
Work to achieve the continuous, secure transfer of data to the CancerLinQ system from patients associated with practices that both participate in CancerLinQ and use the EHR; and
Participate in efforts among stakeholders in the cancer community to drive improvement of interoperability, establish core data elements, and support efforts to standardize and harmonize data approaches.
